Literature DB >> 17127281

Genetically engineered mice as a model for studying cardiac arrhythmias.

Juan Tamargo1, Ricardo Caballero, Lucía Núñez, Ricardo Gómez, Miguel Vaquero, Eva Delpón.   

Abstract

Sudden cardiac death due to ventricular tachyarrhythmias remains an unresolved problem, probably because the mechanisms responsible for the progression of cardiac disease to electrophysiological failure are poorly understood. Genetically engineered mice, the principal mammalian model for studying cardiac electrophysiology, have contributed to the understanding of the genetic, molecular and systemic mechanisms involved in the initiation and/or maintenance of cardiac arrhythmias leading to cardiac death, e.g. cardiac excitability, conduction velocity and refractoriness. Several murine models harbouring human gene mutations leading to electrical and structural cardiac disorders have been developed, including channelopathies (long QT syndrome), familial conduction disorders, cardiomyopathies and other inherited cardiac disorders. This article reviews the results of the main genetically modified mice addressing the genesis of cardiac arrhythmias and sudden cardiac death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17127281     DOI: 10.2741/2046

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  9 in total

1.  Influence of genetic background on ex vivo and in vivo cardiac function in several commonly used inbred mouse strains.

Authors:  Matthew S Barnabei; Nathan J Palpant; Joseph M Metzger
Journal:  Physiol Genomics       Date:  2010-07-13       Impact factor: 3.107

Review 2.  Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research.

Authors:  Alexander Goedel; Ilaria My; Daniel Sinnecker; Alessandra Moretti
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

Review 3.  Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models.

Authors:  Lois Choy; Jie Ming Yeo; Vivian Tse; Shing Po Chan; Gary Tse
Journal:  Int J Cardiol Heart Vasc       Date:  2016-09

4.  Are activated B cells involved in the process of myocardial fibrosis after acute myocardial infarction? An in vivo experiment.

Authors:  Fanrui Mo; Ying Luo; Yuluan Yan; Juan Li; Shayi Lai; Weifeng Wu
Journal:  BMC Cardiovasc Disord       Date:  2021-01-06       Impact factor: 2.298

5.  A Human 3D Cardiomyocyte Risk Model to Study the Cardiotoxic Influence of X-rays and Other Noxae in Adults.

Authors:  Timo Smit; Esther Schickel; Omid Azimzadeh; Christine von Toerne; Oliver Rauh; Sylvia Ritter; Marco Durante; Insa S Schroeder
Journal:  Cells       Date:  2021-09-30       Impact factor: 6.600

Review 6.  Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited arrhythmias.

Authors:  Silvia G Priori; Carlo Napolitano; Elisa Di Pasquale; Gianluigi Condorelli
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 7.  "Ryanopathies" and RyR2 dysfunctions: can we further decipher them using in vitro human disease models?

Authors:  Yvonne Sleiman; Alain Lacampagne; Albano C Meli
Journal:  Cell Death Dis       Date:  2021-11-01       Impact factor: 8.469

8.  Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Mahmoud Gaballah; Kirsi Penttinen; Joose Kreutzer; Antti-Juhana Mäki; Pasi Kallio; Katriina Aalto-Setälä
Journal:  Cells       Date:  2022-03-19       Impact factor: 6.600

9.  Engineered bacterial voltage-gated sodium channel platform for cardiac gene therapy.

Authors:  Hung X Nguyen; Tianyu Wu; Daniel Needs; Hengtao Zhang; Robin M Perelli; Sophia DeLuca; Rachel Yang; Michael Tian; Andrew P Landstrom; Craig Henriquez; Nenad Bursac
Journal:  Nat Commun       Date:  2022-02-02       Impact factor: 17.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.